Formulation of fixed ratio of insulin glargine / Lixisenatide

摘要

Refers to a Pharmaceutical composition comprising: Lixisenatide) or a pharmaceutically acceptable salt in an interval of 25 ug / ml to 40 ug / ml; and (b) glardina insulin or a pharmaceutically acceptable salt in a range of 65 U / ml to 136 U / ml. also relates to a method of treatment. Said composition is useful in the treatment of Type 1 and type 2 diabetes mellitus